OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

It’s ‘unavoidable’: Apple says it will be forced to raise prices due to the AI boom

Did Warsh and Vance just open the door to higher inflation?

Historic NBA Finals ratings and Fox’s $22 billion Roku deal show live sports are key to winning the streaming wars

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Tech Under Attack After Parler Goes Dark, Twitter Drops

January 11, 2021

(Bloomberg) -- Tech firms tried to contain a mounting backlash against their social media sites, with shares of Twitter Inc. and Facebook Inc. falling in early...

3rdPartyFeeds

Bitcoin Is Tumbling Because Regulators Are Paying Attention

January 11, 2021

Pelosi lays out plan for impeachment of President Trump, Amazon stops hosting social media network Parler, slow vaccine rollout could speed up in coming days...

3rdPartyFeeds • News

: Biden plans to distribute COVID-19 vaccine doses immediately

January 11, 2021

President-elect Joe Biden plans to distribute available doses of the COVID-19 vaccines when he comes into office --- which is the latest proposal made by...

3rdPartyFeeds • News

: CDC officials say people with history of allergic reactions should be monitored after receiving a COVID-19 shot

January 11, 2021

People with a history of severe allergic reactions should be monitored after receiving the first dose of a COVID-19 vaccine and should reconsider getting the...

3rdPartyFeeds

GW Pharmaceuticals provides upbeat total and Epidiolex sales outlooks; stock turns up

January 11, 2021

GW Pharmaceuticals PLC provided an upbeat outlook for fourth-quarter sales, amid strength in sales of Epidiolex, the first cannabis-based drug to be approved...

3rdPartyFeeds

Lululemon forecasts fourth-quarter earnings and sales at the top end of outlook thanks to strong holidays

January 11, 2021

Lululemon has not offered an outlook for the full year due to the ongoing effects of the Covid pandemic. Read more...

3rdPartyFeeds

Parler users unknowingly gave away their personal data in videos they uploaded illegally storming Capitol Hill

January 11, 2021

‘There is nothing you can do to prevent what’s already happened. All you can do is prepare for the fallout’ a message from the North Central Florida Patriots...

3rdPartyFeeds

Tech Under Attack After Parler Goes Dark, Twitter Shares Drop

January 11, 2021

(Bloomberg) -- Tech firms tried to contain a mounting backlash against their social media sites, with shares of Twitter Inc. and Facebook Inc. falling in early...

3rdPartyFeeds

GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones

January 11, 2021

\- Total preliminary net product sales of approximately $148 million for the fourth quarter and approximately $526 million for the full year - \- Total...

3rdPartyFeeds • News

: Want to family members to get COVID-19 vaccination? Try Apple’s tactic for selling AirPods — and these other psychological approaches

January 11, 2021

'It will be tragic if we fail to curtail the virus because Americans refuse to be vaccinated.'

Read More...

Previous 1 … 5,032 5,033 5,034 5,035 5,036 … 8,455 Next
Indices by TradingView

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

June 22, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.